Skip to main content

Abstract

Objective:

This study prospectively evaluated outcomes of OnTrackNY, a statewide coordinated specialty care (CSC) program for treatment of early psychosis in community settings, as well as predictors of outcomes.

Methods:

The sample included 325 individuals ages 16–30 with recent-onset nonaffective psychosis who were enrolled in OnTrackNY and who had at least one three-month follow-up. Clinicians provided data at baseline and quarterly up to one year. Domains assessed included demographic and clinical characteristics, social and occupational functioning, medications, suicidality and violence, hospitalization, and time to intervention. Primary outcomes included the symptoms, occupational functioning, and social functioning scales of the Global Assessment of Functioning (GAF), as adapted by the U.S. Department of Veterans Affairs Mental Illness Research, Education and Clinical Center; education and employment status; and psychiatric hospitalization rate.

Results:

Education and employment rates increased from 40% to 80% by six months, hospitalization rates decreased from 70% to 10% by three months, and improvement in GAF scores continued for 12 months. Female gender, non-Hispanic white race-ethnicity, and more education at baseline predicted better education and employment status at follow-up.

Conclusions:

Individuals with early psychosis receiving CSC achieved significant improvements in education and employment and experienced a decrease in hospitalization rate. Demographic variables and baseline education predicted education and employment outcomes. CSC teams should make particular effort to support the occupational goals of individuals at increased risk of not engaging in work or school, including male participants and participants from racial and ethnic minority groups.
Multielement early psychosis programs, known as coordinated specialty care (CSC), have rapidly expanded in the United States (13). This expansion built upon positive findings from the Recovery After an Initial Schizophrenia Episode (RAISE) project, funded by the National Institute of Mental Health, and was enabled by community mental health block grant federal funding of $25 million starting in 2014 (47). Block grant funding was increased in 2016 to $50 milllion annually (1).
A number of well-controlled international studies found that multielement early psychosis programs led to enhanced treatment engagement (8,9), symptom (810) and functional improvement (8,11,12), medication adherence (12), reduced substance use (9), better quality of life (8,12), increased treatment satisfaction (9), and fewer hospitalizations (8,12). The first U.S. controlled study of a multielement early psychosis program found that the program was associated with decreased hospitalization and increased vocational engagement (13). The RAISE Early Treatment Program (ETP) study found that CSC was associated with increased treatment engagement, improved quality of life, and greater symptom reduction compared with usual care (5). A recent review of multicomponent interventions for early psychosis found that these interventions had significant advantages over usual care, including reduced treatment disengagement, symptoms, and hospitalization; improved functioning, treatment satisfaction, and quality of life; greater involvement in school and work; and reduced family burden (14).
Despite the growing evidence base for CSC, little is known about the outcomes of CSC in real-world settings where treatment is not provided as part of a research protocol. New York State (NYS) was an early adopter of CSC and has rapidly expanded its use across the state, providing an important opportunity to understand how research findings translate in real-world, community settings (2). This study prospectively evaluated patient outcomes and their predictors over time at OnTrackNY, the CSC program operated by New York State.

Methods

Participants and Study Design

The total sample included individuals ages 16 to 30 who had experienced nonaffective psychosis for less than two years, were enrolled at one of 10 OnTrackNY sites, and had completed at least one three-month follow-up assessment. OnTrackNY clinicians submit client-level data to the NYS Office of Mental Health (OMH) for quality improvement (QI) and fidelity monitoring purposes; data are submitted at enrollment, at the end of every quarter, and at discharge. Clinicians complete standardized admission, follow-up, and discharge forms quarterly on the basis of chart review and reports from participants and their families. Data collected at admission refer to the 90 days prior to the assessment. Teams at each OnTrackNY site submit program-level data quarterly. For research purposes, all protected health information was removed from the data set. The NYS Psychiatric Institute (NYSPI) Institutional Review Board approved the study procedures.

Intervention

OnTrackNY provides CSC, including evidence-based psychosocial interventions and medication, by a multidisciplinary team. OnTrackNY sites are located in licensed outpatient clinics at community agencies, state-operated facilities, and community and academic hospitals in urban and suburban areas throughout the state. At the time of this study, teams were staffed by 3.5 full-time-equivalent employees, including a team leader, one or more licensed primary clinicians, an outreach and recruitment coordinator, a supported education and employment specialist, a prescriber, and a nurse. Clinicians receive initial training and ongoing technical assistance (TA) from the Center for Practice Innovations, a training and TA center at NYSPI funded by the NYS OMH. The program model specifies that individuals are expected to receive services for an average of two years, although variation in length of treatment is expected. The OnTrackNY model is described more fully elsewhere (2), and intervention manuals are available at www.ontrackny.org/resources.

Measures

Domains assessed included demographic characteristics, diagnosis, substance use, antipsychotic use, and suicidal and violent ideation or behavior. Demographic characteristics included race-ethnicity, age, gender, highest level of education completed at time of admission, and health insurance status. Licensed team clinicians conducted a nonstandardized interview at intake. Because the goal of the interview was to establish a diagnosis of primary, nonaffective psychosis to determine eligibility, clinicians received training in differential diagnosis. Report of substance use included any use of alcohol, marijuana, or other drugs (excluding tobacco) in the 90 days prior to admission. Antipsychotic adherence was operationalized as yes (client was prescribed an antipsychotic in the past 90 days and the clinician reported adherence), no (the client was prescribed an antipsychotic in the past 90 days and the clinician reported nonadherence), or no medications prescribed (antipsychotics were not prescribed in the past 90 days). Adherence was defined as taking at least 80% of the prescribed medication. Clients were not prescribed medication if they chose not to take medication following a shared decision-making process. Suicidal and violent ideation or behavior included any report of suicidal ideation or attempts or of violent or aggressive ideation or behavior in the 90 days prior to admission. Time to intervention was defined as the time from onset of psychosis to enrollment in OnTrackNY.
Primary outcomes included the Global Assessment of Functioning (GAF) (15) symptom, occupational and social functioning scales, as adapted by the U.S. Department of Veterans Affairs Mental Illness Research, Education and Clinical Center (MIRECC) for early psychosis (3); education and employment status; and psychiatric hospitalization rate. Scores on this version of the GAF range from 0 to 100, with scores below 40 considered to be evidence of impairment and scores of 70 and above considered to be in the normal range. Primary clinicians were trained to perform the GAF through didactic instruction and case ratings until reliability was achieved (results within ±5 points of gold standard rating). Participation in school included enrollment in an education program, including high school, vocational training, college, or graduate study, either at admission or follow-up and on a full- or part-time basis. Participation in work included any paid employment, including competitive or noncompetitive work, self-employment, or internship at admission or follow-up. Competitive work was defined as work that pays at least minimum wage, involves a paycheck from the employer, and is not reserved for those with behavioral health problems. Hospitalizations included any psychiatric hospitalizations, excluding substance use rehabilitation or detoxification admissions, in the 90 days prior to admission and in the 90 days prior to each follow-up.

Procedures

Enrollment occurred between October 2013 and August 2016. Approximately 40% of referrals were from inpatient units, 20% were from outpatient mental health providers, and 20% were self-referrals or referrals from family. Other referrals were from schools, community organizations, and emergency departments. The data reported in this study were from admission and months 3, 6, 9, and 12 following enrollment, although the length of the follow-up periods varied by participant, depending on the date of enrollment.

Data Analysis

Differences in rate of discharge or dropout by baseline demographic and clinical characteristics were assessed by using t tests for continuous measures and chi-square tests for categorical measures. To assess outcome trends over time, longitudinal models were fit to each of the five outcomes separately by using generalized estimating equations with an autoregressive covariance structure to account for within-subject correlations over time. Linear models were fit for the three continuous and normally distributed GAF score outcomes, with model estimates interpreted as differences. Logistic models were fit for the binary education or employment status and psychiatric hospitalization outcomes, with model estimates interpreted as log odds ratios. Each model contained a main effect of time (three, six, nine, and 12 months) and assessed baseline site variability by adjusting for each respective outcome measure at admission and for site as a fixed effect. These longitudinal models do not require complete data and provide unbiased results under the assumption that the unobserved values are missing at random (16). A Kaplan-Meier estimator was used to estimate the probability that a client would have a psychiatric rehospitalization or have engaged in any education or employment by 12 months, with three, six, nine, or 12 months as the discrete time to event and censoring at last observed follow-up with no event.
To test how each outcome changed over time, prespecified contrasts were tested from the longitudinal model for the mean change in sequential follow-up visits. These contrasts included mean change from baseline to month 3, from months 3 to 6, from months 6 to 9, and from months 9 to 12. To test which predictors were associated with change in each outcome, we ran longitudinal models that included demographic and clinical characteristics separately as well as models that included both types of characteristic concurrently.
All analyses were run by using SAS, version 9.4, and all statistical tests were two-sided with a p value of 5%. Because analysis of dropout led to no meaningful differences between those who dropped out and those who remained engaged, unobserved values due to dropout were assumed to be missing at random and were not expected to lead to biased results.

Results

Demographic and clinical characteristics of the sample (N=325) are described in Table 1. For 54% of participants, time to intervention was less than six months. There were no differences in baseline demographic and clinical characteristics between those who dropped out before 12 months and those who remained enrolled, except in baseline medication adherence (p=.049) and GAF symptom score (p=.044). Those who were discharged before 12 months were less likely to be taking prescribed medication and were more likely to have higher (better) GAF symptom scores at baseline compared with those who were still enrolled at 12 months.
TABLE 1. Baseline characteristics of 325 participants in coordinated specialty care
CharacteristicN%
Demographic characteristic  
 Age (years)  
  <185517
  18–2010934
  21–2310432
  ≥245718
 Gender  
  Female9028
  Male23572
 Highest education level  
  Less than high school9228
  High school or GED5718
  Some college14143
  College graduate3511
 Parents' highest education level  
  Less than high school124
  High school or GED6620
  Some college3210
  College graduate11836
  Unknown9730
 Race-ethnicity  
  Non-Hispanic white9128
  Non-Hispanic black12338
  Asian3110
  Hispanic6921
  Mixed103
 Insurance status  
  Uninsured309
  Public15147
  Private13642
  Other83
Predictor variable  
 Time to intervention (months)a  
  <617654
  6–128426
  >126520
 Substance use  
  No18156
  Yes14444
 Medication adherence  
  No3310
  Yes24074
  None prescribed289
  Unknown247
 Suicidal ideation or behavior  
  No22770
  Yes9830
 Violent ideation or behavior  
  No24876
  Yes7724
Outcome at baseline  
 GAF scale score (M±SD)b  
  Social functioning55.8±17.9 
  Occupational functioning36.5±20.5 
  Symptoms34.5±16.3 
 Education or employment  
  Neither18156
  Employed only3310
  In school only9429
  Both175
 Competitive employment, if employed  
  No612
  Yes4488
 Psychiatric hospitalization  
  No9228
  Yes23372
a
Measured from onset of psychosis (median=5.3 months)
b
GAF, Global Assessment of Functioning. Possible scores range from 0 to 100, with higher scores indicating better functioning or fewer symptoms.
A total of 133 (41%) participants had complete data for up to 12 months. Sixteen percent were discharged or dropped out before 12 months, and 43% were censored before 12 months (because of staggered enrollment) (Table 2). Program evaluation data were also reported for QI purposes just after data were deidentified in August 2016. These data indicated that 334 individuals were enrolled during the study period and that 99% (N=329) were retained at three months. The slight lag between the time of deidentification and the QI report explains why there were 325 individuals in this study and 329 in the QI report.
TABLE 2. Timing of discharge among 325 participants in coordinated specialty care, by follow-up period
  Discharged 
Follow-up periodNN%Censoreda
3–6 months32517546
6–9 months26216650
9–12 months196201043
12 months133
Total3255316
a
Last observed follow-up
Figure 1 demonstrates the model-estimated mean scores for the GAF over time and the model-estimated prevalence of engagement in education or employment and psychiatric hospitalization over time. The mean GAF score at baseline across the 10 sites ranged from 35.2 to 65.5 for social functioning, 25.5 to 54.0 for occupational functioning, and 25.4 to 43.1 for symptoms. Whereas more than 70% of participants were hospitalized in the three months prior to enrollment, the hospitalization rate following enrollment decreased to an estimated 10% per quarter. The estimated risk of rehospitalization for a psychiatric condition within one year of enrollment was 34% (95% confidence interval [CI]=28%–41%).
FIGURE 1. Mean GAF scores and rates of employment or education and hospitalization among participants in coordinated specialty care during one-year follow-upa
aAdjusted mean (A) and prevalence (B) values were obtained from longitudinal mixed models that controlled for demographic and predictor measures. Higher mean scores indicate better functioning or fewer symptoms. Values at baseline (admission) are unadjusted. Horizontal bars indicate standard error. GAF, Global Assessment of Functioning
Approximately 40% of participants were engaged in school or work at baseline, which increased to an estimated 80% by six months. The estimated probability of being employed or in school at some time during the year after admission was 88% (CI=83%–92%). At baseline, 10% of clients were employed only, 29% were in school only, and 5% were both employed and in school. Of the 50 clients who were employed, 44 (88%) had a competitive job. Of the 260 clients with data at six-month follow-up, 77 (30%) were employed only, 75 (29%) were in school only, and 47 (18%) were both employed and in school. Of the 124 clients who were employed, 81 (65%) had a competitive job.
Table 3 reports the estimated change in outcomes between each time point. The greatest improvement in GAF scores and education or employment status occurred between baseline and three months, with continued improvement to month 6. Statistically significant improvements in social functioning scores were seen at each additional time point, whereas symptom scores continued to improve through month 9. Statistically significant reductions in hospitalization were seen from baseline to month 3 and from months 3 to 6, and hospitalization rates remained low thereafter. [A table showing the percentage of clients with GAF scores >40 and >70 is available in the online supplement.]
TABLE 3. Change in outcomes over time among 325 participants in coordinated specialty carea
  GAF scaleb
  Social functioningOccupational functioningSymptomsEducation or employmentHospitalization
Time periodN at follow-upMean diff.SEpMean diff.SEpMean diff.SEpORpORp
Baseline to 3 months3257.71.60<.00114.021.17<.00112.90.81<.0013.29<.001.05<.001
3 to 6 months2613.05.68<.0014.791.14<.0014.70.82<.0011.87<.001.58.033
6 to 9 months1961.68.62.0071.431.21.2362.85.88.0011.06.7631.26.466
9 to 12 months1331.79.67.0062.411.27.0581.751.30.1771.13.5641.61.124
a
For each outcome, the model included all demographic, baseline, and predictor variables simultaneously and controlled for follow-up time and follow-up site.
b
GAF, Global Assessment of Functioning
Table 4 shows the estimated effects of predictors on longitudinal outcomes. Site was significantly associated with all GAF outcomes (social functioning, χ2=27.30, df=9, p=.001; occupational functioning, χ2=26.59, df=9, p=.002; and symptoms, χ2=19.06, df=9, p=.025) but not with education or employment or hospitalization. However, only 4% of the variability in baseline social functioning scores was due to site, compared with 7% of the variability in occupational scores and 5% for symptom scores (data not shown). Baseline scores in each domain were highly associated with subsequent scores in that domain, and baseline participation in education or employment was highly associated with subsequent education or employment.
TABLE 4. Predictors of longitudinal outcomes among 325 participants in coordinated specialty carea
 GAF scaleb
 Social functioningOccupational functioningSymptomsEducation or employmentHospitalization
PredictorBetaSEpBetaSEpBetaSEpLog oddsSEpLog oddsSEp
Baseline respective outcome.45.05<.001.32.05<.001.35.05<.0012.08.34<.001–.08.34.804
Baseline education or employment1.841.21.1272.041.64.212–.30.27.268
Baseline GAF symptoms–.04.03.206.09.07.229.01.01.098–.03.01.006
Age (years).22.21.285–.90.44.042–.21.30.472–.09.05.065–.03.07.712
Male (reference: female)–1.001.21.409–6.992.37.003–2.451.88.191–.70.32.028–.45.31.144
Highest education level (reference: less than high school)               
 High school or GED1.141.87.542–2.813.21.3812.662.38.264–.76.35.030–.15.44.726
 Some college2.091.50.1634.852.85.0894.972.03.015–.18.35.597–.30.39.435
 College graduate1.302.54.6108.935.41.0994.183.44.224–.05.59.927–1.17.89.189
Parents’ highest education level (reference: less than high school)               
 High school or GED1.002.49.6887.005.58.209.022.66.995.25.62.683.70.47.136
 Some college2.312.56.3684.016.16.514–3.233.48.354–.16.67.808–.29.59.621
 College graduate1.122.45.6482.535.71.658–3.372.74.219–.13.62.839.57.51.262
 Unknown.792.41.7424.485.53.418–.662.75.810.24.63.706–.27.51.605
Race (reference: non-Hispanic white)               
 Non-Hispanic black.841.71.626–5.522.97.063–.092.06.964–1.02.36.005.13.39.73
 Asian–2.771.85.135–8.904.19.034–1.452.55.568–1.11.49.024.60.53.257
 Hispanic–2.802.03.167–12.123.70.001–2.442.27.281–1.08.44.014.26.43.546
 Mixed–.432.45.860–4.844.43.275–3.903.69.290–.87.62.1641.18.61.051
Time to intervention in daysc–.01.09.931–.27.16.103–.46.12<.001.01.02.854.01.02.492
Substance use (reference: none)1.741.16.133–1.842.09.379.561.61.729.19.24.431.24.29.404
Medication adherence (reference: no)               
 Yes1.261.27.321–1.691.66.3082.671.46.068–.23.31.458.20.33.558
 No medications prescribed2.191.50.1442.852.18.1927.172.07<.001.07.37.851–1.29.67.056
 Unknown.002.891.000–.514.23.904–.054.99.992–.16.66.810.94.64.140
Suicidal ideation or behavior (reference: none)            –.08.27.764
Violent ideation or behavior (reference: none)            .33.27.211
a
Longitudinal outcomes reflect all follow-up periods (3, 6, 9, and 12 months). For each outcome, the model included all demographic, baseline, and predictor variables simultaneously and controlled for follow-up time and follow-up site.
b
GAF, Global Assessment of Functioning
c
Measured from onset of psychosis
Compared with women, men had significantly lower (worse) occupational scores and lower odds of being in school or employed. Compared with non-Hispanic whites, Asians and Hispanics had significantly lower occupational scores and lower odds of education or employment. Compared with non-Hispanic whites, blacks had lower odds of education or employment. Compared with individuals who had not yet completed high school, individuals with a high school degree or GED had lower educational or employment status at follow-up. Having some college (versus less than a high school degree), shorter time from onset of psychosis to program enrollment, and medication not prescribed (versus nonadherence) predicted higher (better) symptom scores. A lower (worse) baseline symptom score was associated with higher odds of having a psychiatric hospitalization. We repeated the analysis while controlling for parents’ highest education, with the only difference being that age became significantly associated with the occupational score. Older clients had significantly lower (worse) occupational scores.
To determine whether some predictors that were not significantly associated with outcomes would become significant if the analyses did not control for the other predictors, we repeated the analyses, this time controlling for baseline demographic characteristics and baseline outcomes but not mutually controlling for other predictors. We found no differences in significance between the approaches, except that compared with medication nonadherence, not being prescribed an antipsychotic was significantly associated with lower odds of a psychiatric hospitalization.

Discussion

This is the first large-scale report of outcomes from a CSC program in the United States that is not part of a research study. The data demonstrate improved symptoms and occupational and social functioning, increased education and employment status, and decreased hospitalization rate. The greatest gains were seen in the first three months following enrollment, with continued improvement over time.
Participation in school or work was comparable to or exceeded rates seen in other CSC studies (5,13). OnTrackNY programs have a full-time supported employment and education specialist, which has been shown to improve vocational outcomes (17). The increased participation in school and work among OnTrackNY participants may also be due to the fact that the duration of untreated psychosis (DUP) among participants in this study was relatively short, compared with studies that did not limit DUP. Eligibility for OnTrackNY services is limited to individuals with DUP of less than two years; DUP in this study was an average of 225 days (median=160 days, or 5.3 months). Shorter DUP has been associated with better outcomes overall (14,18) and improved school or work outcomes (1921). The shorter time to intervention may be due in part to the emphasis on outreach; each OnTrackNY has a part-time outreach and recruitment coordinator responsible for outreach (equal to .5 full-time-equivalent positions, approximately). DUP was longer in the RAISE-ETP study, which limited enrollment based on prior treatment but not duration of psychosis; the median DUP in the RAISE-ETP study was 74 weeks (5).
Rates of enrollment in the Supplemental Security Income (SSI) or the Social Security Disability Insurance (SSDI) programs among participants in OnTrackNY were somewhat lower than those observed in the RAISE-ETP study (22,23). In that study, the mean±SE percentage of participants enrolled in SSI/SSDI at baseline was 14%±2.9% for those enrolled in community care (CC) and 6%±1.5% for those enrolled in Navigate, the CSC model tested in the study. Rates rose to 36%±4.2% and 34%±3.2% at one year and to 48%±5.8% and 55%±4.2% at two years for CC and Navigate, respectively. In OnTrackNY, only 3% of individuals received SSI/SSDI at baseline. Participation was estimated to be 11% (CI=9%–15%) at one year and 18% (CI=14%–24%) at two years (1421,2426). Notably, some participants in the RAISE-ETP study may have needed to apply for SSI/SSDI in order to obtain Medicaid and receive treatment services, which was likely a factor in the SSI/SSDI participation rates in the RAISE-ETP study. It is possible that OnTrackNY participants were less reliant on applying for SSI/SSDI as a strategy to obtain health care coverage because OnTrackNY services are provided regardless of insurance status. We did not assess whether disability at baseline was a predictor of participation in work or school because baseline rates of disability were relatively low. Also, given the relatively high rates of employment and school participation, we anticipated that receipt of SSI/SSDI would result from poor work and school functioning rather than the other way around.
Other studies of early psychosis have also found that baseline levels of education and employment predicted school and work outcomes (19,20,24,25). We were not able to measure baseline cognitive and premorbid functioning, which have been found to predict vocational outcomes in first-episode psychosis (FEP) (2527).
It is noteworthy that social functioning improved over every time point and that the percentage of clients with scores in the normal range was higher for social functioning than for the other GAF subscales at every time point. Other studies have also found that baseline social functioning predicted follow-up social functioning (28). Similar improvements in social functioning have been seen in other FEP studies (29).
Compared with medication nonadherence, no medication prescription was associated with higher (better) symptom scores. That may be because those with fewer symptoms were less likely to agree to antipsychotic medication.
The rate of hospitalization, 34% in one year, was similar to the rates in other studies of CSC. In the RAISE-ETP study, 34% of participants in CSC and 37% of participants in community care were hospitalized over a two-year period. In the Specialized Treatment in Early Psychosis study, 24% of participants in CSC and 44% in usual treatment (5,13) were hospitalized. Reductions in hospitalization are to be expected given the high rates of recent hospitalization at enrollment. Other studies have identified prior hospitalization, older age, lower GAF scores, and substance use as predictors of hospitalization (3032).
Of note, substance use was not a significant predictor of any of the outcomes studied. This finding differs from some of the literature. Lower use or no use of substances has been identified as a predictor of recovery, and substance use has been identified as a negative predictor of education and employment (25,33,34). Substance use may have been underreported, given that we did not use a standardized assessment or collect self-report or collateral data.
The study was limited by the constraints of data collection in a context not associated with research. First, without a control condition, we cannot say that OnTrackNY caused the observed outcomes. All ratings were performed by clinical staff and, therefore, were subject to clinician bias. Diagnosis, substance use, and medication adherence were not determined by using a structured interview or tool. We did not use self-report or collateral measures and did not examine which components of the model were utilized. Although teams were closely monitored for adherence to the clinical model, we did not utilize a formal fidelity scale, although one is in development. OnTrackNY has the benefit of strong state support, including funding for a statewide TA center.

Conclusions

This study demonstrated that providing CSC in community settings and not as part of a research protocol was associated with significant improvements in education and employment and a decrease in the hospitalization rate among individuals with early psychosis. Several demographic variables and baseline education predicted education and employment outcomes. CSC teams should make particular effort to support the work and school goals of individuals who may be more likely to struggle in achieving engagement in work and school, including male participants and participants from racial and ethnic minority groups.

Supplementary Material

File (appi.ps.201700436.ds001.pdf)

References

1.
Dixon L: What will it take to make coordinated specialty care available to anyone experiencing early schizophrenia: getting over the hump. JAMA Psychiatry 74:7–8, 2017
2.
Bello I, Lee R, Malinovsky I, et al: OnTrackNY: the development of a coordinated specialty care program for individuals experiencing early psychosis. Psychiatric Services 68:318–320, 2017
3.
Heinssen RK, Goldstein AB, Azrin ST: Evidence-Based Treatments for First Episode Psychosis: Components of Coordinated Specialty Care. Bethesda, MD, National Institute of Mental Health, 2014. https://www.nimh.nih.gov/health/topics/schizophrenia/raise/nimh-white-paper-csc-for-fep_147096.pdf
4.
Dixon LB, Goldman HH, Bennett ME, et al: Implementing coordinated specialty care for early psychosis: the RAISE Connection Program. Psychiatric Services 66:691–698, 2015
5.
Kane JM, Robinson DG, Schooler NR, et al: Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. American Journal of Psychiatry 173:362–372, 2016
6.
Breitborde NJ, Bell EK, Dawley D, et al: The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service. BMC Psychiatry 15:266, 2015
7.
Dixon LB, Goldman HH, Srihari V, et al: Transforming the treatment of schizophrenia in the US: the RAISE initiative. Annual Review of Clinical Psychology (Epub ahead of print, Jan 12, 2018)
8.
Guo X, Zhai J, Liu Z, et al: Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: a randomized, 1-year study. Archives of General Psychiatry 67:895–904, 2010
9.
Secher RG, Hjorthøj CR, Austin SF, et al: Ten-year follow-up of the OPUS specialized early intervention trial for patients with a first episode of psychosis. Schizophrenia Bulletin 41:617–626, 2015
10.
Grawe RW, Falloon IR, Widen JH, et al: Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica 114:328–336, 2006
11.
Craig TK, Garety P, Power P, et al: The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. British Medical Journal 329:1067, 2004
12.
Gafoor R, Nitsch D, McCrone P, et al: Effect of early intervention on 5-year outcome in non-affective psychosis. British Journal of Psychiatry 196:372–376, 2010
13.
Srihari VH, Tek C, Kucukgoncu S, et al: First-episode services for psychotic disorders in the US public sector: a pragmatic randomized controlled trial. Psychiatric Services 66:705–712, 2015
14.
Fusar-Poli P, McGorry PD, Kane JM: Improving outcomes of first-episode psychosis: an overview. World Psychiatry 16:251–265, 2017
15.
Niv N, Cohen AN, Sullivan G, et al: The MIRECC version of the Global Assessment of Functioning scale: reliability and validity. Psychiatric Services 58:529–535, 2007
16.
Little RJA, Rubin DB: Statistical Analysis With Missing Data, 2nd ed. New York, Wiley,2002
17.
Dudley R, Nicholson M, Stott P, et al: Improving vocational outcomes of service users in an early intervention in psychosis service. Early Intervention in Psychiatry 8:98–102, 2014
18.
Marshall M, Lewis S, Lockwood A, et al: Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of General Psychiatry 62:975–983, 2005
19.
Tapfumaneyi A, Johnson S, Joyce J, et al: Predictors of vocational activity over the first year in inner-city early intervention in psychosis services. Early Intervention in Psychiatry 9:447–458, 2015
20.
Conus P, Cotton S, Schimmelmann BG, et al: Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis. Social Psychiatry and Psychiatric Epidemiology 52:1089–1099, 2017
21.
Díaz I, Pelayo-Terán JM, Pérez-Iglesias R, et al: Predictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables. Psychiatry Research 206:181–187, 2013
22.
Humensky J, Scodes J, Wall M, et al: Disability enrollment in a community-based coordinated specialty care program. American Journal of Psychiatry 174:1224-1225, 2017
23.
Rosenheck RA, Estroff SE, Sint K, et al: Incomes and outcomes: Social Security disability benefits in first-episode psychosis. American Journal of Psychiatry 174:886–894, 2017
24.
Chang WC, Kwong VW, Chan GH, et al: Prediction of functional remission in first-episode psychosis: 12-month follow-up of the randomized-controlled trial on extended early intervention in Hong Kong. Schizophrenia Research 173:79–83, 2016
25.
Chang WC, Man Tang JY, Ming Hui CL, et al: Clinical and cognitive predictors of vocational outcome in first-episode schizophrenia: a prospective 3-year follow-up study. Psychiatry Research 220:834–839, 2014
26.
Dickerson FB, Stallings C, Origoni A, et al: Predictors of occupational status six months after hospitalization in persons with a recent onset of psychosis. Psychiatry Research 160:278–284, 2008
27.
Humensky JL, Essock SM, Dixon LB: Characteristics associated with the pursuit of work and school among participants in a treatment program for first episode of psychosis. Psychiatric Rehabilitation 40:108–112, 2017
28.
Simonsen E, Friis S, Haahr U, et al: Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors. Acta Psychiatrica Scandinavica 116:54–61, 2007
29.
Gonzalez-Blanch C, Gleeson JF, Koval P, et al:. Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study. PLoS ONE 10: e0122404, 2015
30.
Turner MA, Boden JM, Mulder RT: Predictors of hospitalization two years after treatment for first-episode psychosis. Psychiatric Services 64:1230–1235, 2013
31.
Addington DE, Beck C, Wang J, et al: Predictors of admission in first-episode psychosis: developing a risk adjustment model for service comparisons. Psychiatric Services 61:483–488, 2010
32.
Batalla A, Garcia-Rizo C, Castellví P, et al: Screening for substance use disorders in first-episode psychosis: implications for readmission. Schizophrenia Research 146:125–131, 2013
33.
Petersen L, Thorup A, Øqhlenschlaeger J, et al: Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial. Canadian Journal of Psychiatry 53:660–670, 2008
34.
Conus P, Cotton SM, Francey SM, et al: Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication. Schizophrenia Research 185:130–136, 2017

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Green Plums, by Joseph Decker, circa 1885. Oil on canvas. Collection of Mr. And Mrs. Paul Mellon, National Gallery of Art, Washington, D.C.

Psychiatric Services
Pages: 863 - 870
PubMed: 29759055

History

Received: 4 October 2017
Revision received: 29 January 2018
Revision received: 12 March 2018
Accepted: 28 March 2018
Published online: 15 May 2018
Published in print: August 01, 2018

Keywords

  1. Community mental health services
  2. Schizophrenia
  3. Young adults with CMI

Authors

Details

Ilana Nossel, M.D. [email protected]
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Melanie M. Wall, Ph.D.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Jennifer Scodes, M.S.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Leslie A. Marino, M.D., M.P.H
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Sacha Zilkha, Ph.D.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Iruma Bello, Ph.D.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Igor Malinovsky, Psy.D.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Rufina Lee, Ph.D.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Marleen Radigan, Dr.P.H.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Thomas E. Smith, M.D.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Lloyd Sederer, M.D.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Gyojeong Gu, M.P.P.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.
Lisa Dixon, M.D., M.P.H.
Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Marino, Dr. Zilkha, Dr. Bello, Dr. Malinovsky, and Dr. Dixon are with the New York State Psychiatric Institute, New York. Dr. Nossel, Dr. Wall, Ms. Scodes, Dr. Bello, Dr. Malinovsky, Dr. Smith, and Dr. Dixon are also with the Department of Psychiatry, Columbia University Medical Center, New York. Dr. Smith is also with the New York State Office of Mental Health, Albany, where Dr. Radigan, Dr. Sederer, and Mr. Gu are affiliated. Dr. Lee is with the Silberman School of Social Work, Hunter College, New York.

Notes

Send correspondence to Dr. Nossel (e-mail: [email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share